» Articles » PMID: 26298184

Impact of Being Underweight on the Long-term Outcomes of Patients with Gastric Cancer

Overview
Journal Gastric Cancer
Date 2015 Aug 24
PMID 26298184
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to investigate the impact of being underweight on the long-term outcomes of gastric cancer patients.

Methods: This study reviewed the medical records of 638 patients with gastric cancer who underwent gastrectomy between January 2003 and December 2011. The patients were divided into three groups according to the WHO classification: underweight (BMI <18.5 kg/m(2)), normal weight (BMI ≥18.5 and <25 kg/m(2)), and overweight (BMI ≥25 kg/m(2)). A multivariate analysis was performed to identify prognostic factors.

Results: The mean BMI immediately before surgery was 22.5 kg/m(2) (standard deviation, 3.3 kg/m(2)). According to the BMI subgroup, 73 patients (11.4 %) were underweight, 431 patients (67.6 %) were of normal weight, and 134 patients (21 %) were overweight. The 5-year overall survival (OS) rate was 66.6 % in the underweight patients, 81.3 % in the normal weight patients, and 79.9 % in the overweight patients (P = 0.001). The OS rate was significantly lower in the underweight patients than in the normal weight and overweight patients among those with stage I disease, and it was also lower than in the normal weight patients among those with stage II and III disease. In the multivariate analysis, being underweight was found to be an independent predictor of OS, but it was not an independent predictor among patients with stage II and III disease.

Conclusions: Being underweight is a simple and reliable predictor of a worse long-term outcome among gastric cancer patients. Being underweight is considered to be associated with a higher risk of non-cancer death.

Citing Articles

Prognostic value of [Ga]Ga-FAPI-04 PET in patients with newly diagnosed gastric carcinoma.

Qin C, Fu Y, Zhang X, Li M, Ruan W, Gai Y Eur J Nucl Med Mol Imaging. 2025; .

PMID: 40016528 DOI: 10.1007/s00259-025-07164-8.


Association of preoperative body mass index with postoperative complications and survival for patients with gastric cancer: A systematic review and meta-analysis.

Li Z, Cui L, Sun J, Liu W PLoS One. 2025; 20(1):e0317985.

PMID: 39874306 PMC: 11774357. DOI: 10.1371/journal.pone.0317985.


Impact of Lymphocyte/Monocyte Ratio on Outcomes in Patients with Remnant Gastric Cancer After Gastrectomy.

Shimizu S, Matsunaga T, Saito H, Osaki T, Fukuda K, Fukumoto Y Yonago Acta Med. 2024; 67(4):314-320.

PMID: 39583766 PMC: 11584237. DOI: 10.33160/yam.2024.11.006.


Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China.

Luan X, Zhao L, Zhang F, Wang W, Jiao F, Zhou X BMC Cancer. 2024; 24(1):1149.

PMID: 39285317 PMC: 11403820. DOI: 10.1186/s12885-024-12873-8.


Modifiable risk factors for weight loss after cancer treatment in Korean gastric cancer survivors.

Park J, Kim J, Shin D, Shin J, Cho B, Song Y J Cancer Surviv. 2024; .

PMID: 39083113 DOI: 10.1007/s11764-024-01642-y.


References
1.
Sierzega M, Kolodziejczyk P, Kulig J . Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010; 97(7):1035-42. DOI: 10.1002/bjs.7038. View

2.
Bickenbach K, Denton B, Gonen M, Brennan M, Coit D, Strong V . Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol. 2012; 20(3):780-7. DOI: 10.1245/s10434-012-2653-3. View

3.
DeWys W, Begg C, Lavin P, Band P, Bennett J, Bertino J . Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980; 69(4):491-7. DOI: 10.1016/s0149-2918(05)80001-3. View

4.
Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T . Underweight patients show an increased rate of postoperative death after surgery for hepatocellular carcinoma. J Surg Oncol. 2011; 104(7):809-13. DOI: 10.1002/jso.22049. View

5.
Alici S, Kaya S, Izmirli M, Tuncer I, Dogan E, Ozbek H . Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit. 2006; 12(5):CR221-9. View